tryptamine has been researched along with Infarction, Middle Cerebral Artery in 1 studies
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Su, JH | 1 |
| Wu, GP | 1 |
| Peng, X | 1 |
| Zhao, GQ | 1 |
| Peng, Y | 1 |
| Zhang, HH | 1 |
| Zhao, YT | 1 |
| Sun, R | 1 |
| Chen, ST | 1 |
| Tian, Y | 1 |
| Wang, Z | 1 |
1 other study available for tryptamine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Neuroprotective Effects of an
Topics: Apoptosis; bcl-2-Associated X Protein; Brain Ischemia; Humans; Infarction, Middle Cerebral Artery; N | 2023 |